Research Insight

Global Digital Twin Market Size & Future Industry Analysis

 

The global digital twin market size is expected to grow from USD 21.14 billion in 2025 to USD 149.81 billion in 2030 at a CAGR of 47.9% over the forecast period. The adoption of digital twin technology is revolutionizing operations across sectors by enabling real-time monitoring, simulation, and predictive maintenance. Integration with IoT, AI, and machine learning allows businesses to create precise virtual replicas of physical assets, processes, and systems to optimize performance and reduce downtime.

• Published: February 2026

Hexagon AB and Carl Zeiss AG are Leading Players in the Inline Metrology Market

The inline metrology market is projected to reach USD 3.80 billion by 2032 from USD 2.63 billion in 2026, at a CAGR of 6.3%.

• Published: February 2026

Process Oil Companies: Shell plc (UK) and Exxon Mobil Corporation (US) are Leading Players in the Process Oil Market

The global process oil market is projected to grow from USD 5.38 billion in 2025 to USD 6.16 billion by 2030, at a CAGR of 2.8% during the forecast period. Process oils are specialty oils used as functional formulation components in industrial manufacturing to enhance processing efficiency, material flexibility, and overall product consistency. They are incorporated during the compounding and mixing stages to improve flow behavior, ensure uniform dispersion of fillers, and reduce internal friction, enabling smoother, more reliable production across a range of applications. Process oils commonly function as extender oils and plasticizers, helping manufacturers optimize formulations while maintaining required mechanical properties and cost efficiency. The market for process oils is growing as material-intensive manufacturing activities that depend on rubber and polymer processing expand, where stable processing conditions and consistent output quality are essential. Increasing production volumes and more complex material formulations are driving steady consumption, as process oils remain critical to achieving desired performance characteristics. In addition, evolving regulatory and safety expectations are influencing the selection of process oil grades, driving a gradual shift toward compliant, higher-quality alternatives. This transition supports value growth while maintaining overall demand. Together, the essential role of process oils in manufacturing workflows, ongoing industrial expansion, and formulation upgrades driven by performance and compliance needs are supporting the sustained growth of the process oil market. 

• Published: February 2026

Johnson Controls and Honeywell are Leading Players in the Healthcare Mass Notification System Market

The healthcare mass notification system market is projected to grow from USD 3.53 billion in 2025 to USD 11.27 billion by 2030, at a CAGR of 26.1%, during the forecast period. The market is expanding due to the need to ensure timely and adequate information dissemination during routine operations and emergencies. Vendors are now offering advanced MNS platforms that include features like wearable panic buttons, mobile app enhancements, and dynamic targeting. These innovations enable more precise and effective communication, tailored to the specific needs of healthcare environments. Honeywell and Siemens focus on hardware-software hybrids for large healthcare facilities, Singlewire on IP-based systems, and BlackBerry AtHoc on secure, encrypted notifications.

• Published: February 2026

Global PCR & Real-Time PCR Molecular Diagnostics Market - Strategic Industry Overview

The PCR & real-time PCR molecular diagnostics market is experiencing strong momentum, fueled by rising demand for rapid and highly accurate testing solutions across hospitals, reference laboratories, and research institutions. Growth is evident across applications such as pathogen detection, oncology diagnostics, genetic analysis, and personalized medicine. Ongoing investments in advanced molecular platforms, reagents, and automated systems are accelerating enterprise-level adoption, while increasing emphasis on precision diagnostics and laboratory automation is improving workflow efficiency and data reliability. Strategic collaborations among instrument manufacturers, diagnostic labs, and biotechnology firms continue to strengthen the overall market ecosystem.

• Published: February 2026

Global Thyroid Cancer Molecular Diagnostics Market - Strategic Industry Overview

The thyroid cancer molecular diagnostics market is experiencing steady expansion, supported by growing emphasis on early detection and precision-driven treatment approaches. Demand for genetic testing, molecular profiling, and biomarker-based diagnostics continues to rise as healthcare providers seek more accurate diagnosis, effective risk stratification, and personalized therapy planning. Technologies such as next-generation sequencing, PCR-based assays, liquid biopsy platforms, and companion diagnostics are central to market growth. Increasing adoption across hospitals, cancer centers, and diagnostic laboratories, along with strategic collaborations between diagnostics companies, biotechnology firms, and research institutions, is strengthening the overall market ecosystem.

• Published: February 2026

Global Kidney Cancer Molecular Diagnostics Market - Strategic Industry Overview

The kidney cancer molecular diagnostics market is experiencing steady expansion, supported by the growing emphasis on precision oncology and the integration of advanced molecular testing into routine clinical practice. Healthcare providers are increasingly adopting genomics-based assays, liquid biopsies, and companion diagnostics to enable targeted therapy selection and personalized treatment strategies. Hospitals and laboratories are strengthening their molecular testing capabilities to improve detection of genetic mutations and clinically relevant biomarkers associated with renal cancers. Strategic collaborations between diagnostic developers, pharmaceutical companies, and research institutions are further advancing high-throughput assay development and standardized protocols. Additionally, the focus on early diagnosis, therapy monitoring, and outcome prediction continues to shape the evolving landscape of kidney cancer molecular diagnostics.

• Published: February 2026

Global Liver Cancer Molecular Diagnostics Market - Strategic Industry Overview

The liver cancer molecular diagnostics market is witnessing strong momentum as healthcare providers increasingly emphasize early detection, biomarker-driven testing, and personalized treatment approaches. Adoption of advanced molecular platforms such as liquid biopsies, next-generation sequencing, and PCR-based assays is expanding across diagnostic laboratories and oncology centers. Growth is supported by rising disease burden, greater clinical awareness of molecular testing benefits, and deeper integration of diagnostic tools into routine care pathways to enhance patient outcomes. In addition, strategic collaborations among diagnostic companies, research institutions, and healthcare providers are strengthening the innovation ecosystem, while the broader shift toward precision medicine and value-based care continues to accelerate clinical adoption.

• Published: February 2026

Henkel Corporation (Germany) and Parker Hannifin Corp (US) are the leading key players in the Electronic Potting Compound Market

The electronic potting compound market for EV charger is projected to grow from an estimated USD 0.36 billion in 2025 to USD 0.96 billion by 2032, registering a CAGR of 14.9%. Thermal curing remains dominant in EV charger potting due to its effectiveness in thick encapsulation layers used in high-power DC fast chargers, providing uniform curing, strong electrical insulation, and long-term thermal stability. The increasing adoption of 800 V+ architectures and megawatt charging systems further strengthens demand for thermally cured materials, as they ensure reliable performance under continuous high-load conditions. UV-assisted hybrid curing technologies are being increasingly adopted in automated manufacturing environments, as they enable rapid surface curing for quicker handling while a secondary thermal cure ensures complete material performance. Manufacturers are increasingly optimizing cure profiles to minimize exotherm and internal stress in dense power assemblies. Additionally, curing systems compatible with inline, automated production lines are becoming essential to support high-volume charger manufacturing.

 

• Published: February 2026

Global Precancer Molecular Diagnostics Market - Strategic Industry Overview

The precancer molecular diagnostics market is experiencing strong momentum, supported by the growing emphasis on early-stage cancer detection and the rising demand for minimally invasive diagnostic solutions. Healthcare providers are increasingly integrating molecular testing into routine clinical workflows to enhance early diagnosis, improve patient outcomes, and optimize treatment pathways. Key growth areas include biomarker analysis, genetic screening, liquid biopsy technologies, and advanced molecular assays. Market expansion is further shaped by sustained research and development efforts, collaborative public–private initiatives, and the broader adoption of precision oncology strategies. Strategic partnerships between pharmaceutical and diagnostic companies continue to strengthen test accuracy, scalability, and seamless integration with hospital laboratory systems.

• Published: February 2026

Global Brain Cancer Molecular Diagnostics Market - Strategic Industry Overview

The brain cancer molecular diagnostics market is experiencing strong momentum as the rising burden of brain tumors and the growing emphasis on precision medicine drive demand for advanced molecular testing. Healthcare providers are increasingly focusing on early detection, personalized treatment strategies, and targeted therapy monitoring, accelerating the integration of genomic research and bioinformatics into clinical workflows. Strategic collaborations between diagnostic companies, research institutions, and hospitals are further advancing biomarker discovery and clinical translation. Key platforms supporting market growth include PCR-based assays, next-generation sequencing, in situ hybridization, and immunohistochemistry technologies for comprehensive tumor profiling.

• Published: February 2026

The Chemours Company (US) and DAIKIN INDUSTRIES, Ltd. (Japan) are Leading Players in the Fluoropolymers Market

The fluoropolymers market is projected to reach USD 14.13 billion by 2030 from USD 10.32 billion in 2025, at a CAGR of 6.5% during the forecast period. The market is driven by the increasing demand from the automotive, aerospace, electronics, chemical processing, and renewable energy industries for their excellent chemical resistance, thermal stability, and electrical insulation properties. The rapid expansion of electric vehicles, semiconductor production, and the use of lightweight materials in aerospace is driving adoption. The development of new technologies, including high-purity fluoropolymers, low-PFAS formulations, and enhanced processing methods, is rapidly increasing in the application area. Government initiatives in clean energy, EV adoption, advanced manufacturing, and infrastructure development are among the factors supporting market growth. However, changing environmental regulations are also pushing the industry to develop more sustainable and compliant fluoropolymer solutions, which, in turn, will influence market growth in the long run.

• Published: February 2026

Vietnam Molecular Diagnostics Market - Strategic Industry Overview

The Vietnam Molecular Diagnostics Market is witnessing strong momentum, supported by rising demand for advanced testing technologies and the growing burden of infectious and genetic diseases. Adoption of PCR-based assays, next-generation sequencing, and point-of-care molecular diagnostics is expanding across hospitals, reference laboratories, and research institutions. Increased investments in laboratory automation, data analytics, and integrated diagnostic platforms are enhancing efficiency and scalability. Public and private healthcare providers are prioritizing molecular solutions to improve diagnostic accuracy and clinical outcomes, while partnerships between global diagnostic companies and local distributors are strengthening supply chains and broadening market access.

• Published: February 2026

Global Ovarian Cancer Molecular Diagnostics Market - Strategic Industry Overview

The ovarian cancer molecular diagnostics market is experiencing strong growth, fueled by rising disease prevalence, increasing awareness of early detection, and wider adoption of advanced molecular testing technologies. The market is steadily expanding as genomics and precision medicine become more integrated into oncology care. Key segments include next-generation sequencing, PCR-based assays, companion diagnostics, liquid biopsy platforms, and biomarker-driven testing solutions. Healthcare providers, diagnostic laboratories, and research institutions are investing in these technologies to enable personalized treatment strategies and improve clinical outcomes. At the same time, collaborations between diagnostics companies, pharmaceutical firms, and research organizations are accelerating innovation and commercialization of advanced ovarian cancer testing solutions.

• Published: February 2026

Global Colon Cancer Molecular Diagnostics Market - Strategic Industry Overview

The colon cancer molecular diagnostics market is experiencing strong momentum, supported by rising incidence of colorectal cancer, growing emphasis on early detection, and wider adoption of precision medicine strategies. Increased investment in advanced molecular testing platforms such as PCR-based assays, next-generation sequencing, and liquid biopsy technologies is strengthening the diagnostic landscape. Healthcare providers, laboratories, and pharmaceutical companies are integrating molecular diagnostics into routine clinical pathways, driving enterprise-level adoption and strategic collaborations. Partnerships among diagnostic manufacturers, biotechnology firms, and data analytics providers are enhancing clinical decision support and improving patient outcomes. Overall, spending patterns indicate a clear transition toward personalized, biomarker-driven care and risk-based treatment approaches.

• Published: February 2026

Global Skin Cancer Molecular Diagnostics Market - Strategic Industry Overview

The skin cancer molecular diagnostics market is experiencing strong momentum, fueled by rising disease burden and growing emphasis on early, accurate detection through advanced genomic and biomarker-based technologies. Adoption of high-throughput sequencing, PCR-based assays, and multi-gene panels is increasing across hospitals, diagnostic laboratories, and research institutions, reflecting the integration of molecular testing into routine oncology workflows. Strategic investments in precision medicine and collaborations between diagnostic companies and healthcare providers are further strengthening market expansion. Healthcare stakeholders are prioritizing molecular tools for risk assessment, treatment planning, and personalized therapy selection, while platforms offering multiplex biomarker capabilities, rapid turnaround, and high clinical sensitivity are gaining clear preference in B2B procurement decisions.

• Published: February 2026

Global Allergy Diagnostics and Therapeutics Market - Strategic Industry Overview

The allergy diagnostics and therapeutics market is expanding steadily, supported by the growing burden of allergic conditions, increased clinical awareness, and wider adoption of advanced testing methods and targeted treatment options. Growth is evident across core segments such as in vitro diagnostics, skin testing, immunotherapy, and biologics, reflecting a more integrated approach to allergy management. Healthcare systems are prioritizing investments in precision-driven diagnostic and therapeutic solutions to improve patient outcomes while optimizing cost efficiency. At the enterprise level, digital diagnostic platforms, laboratory automation, and connected monitoring technologies are strengthening operational performance across allergy care networks. Strategic collaborations among pharmaceutical companies, diagnostic developers, and research institutions continue to accelerate innovation in both testing and therapeutic development.

• Published: February 2026

Global Pediatric Allergy Diagnostics Market - Strategic Industry Overview

The pediatric allergy diagnostics market is expanding steadily, supported by the growing burden of childhood allergic conditions and heightened awareness among caregivers about early detection and management. Healthcare facilities are increasingly adopting advanced diagnostic technologies to improve accuracy and streamline clinical workflows. Investment from hospitals, specialized laboratories, and diagnostic service providers is strengthening the shift toward precision-based allergy testing. The rise of telemedicine and integrated care networks is further enabling broader access to pediatric allergy testing in routine practice. Ongoing innovation in non-invasive methods, multiplex assays, and molecular diagnostics, along with strategic partnerships between providers and vendors, is driving the development of comprehensive and patient-centric allergy management solutions.

• Published: February 2026

GE HealthCare (US) and Cardinal Health (US) are the leading key players in the Asia Pacific Nuclear Medicine Market

The Asia Pacific nuclear medicine market is projected to reach USD 4.68 billion by 2030 from USD 2.13 billion in 2025, registering a CAGR of 17.1% during the forecast period. This regional market growth is due to the scale-up of radiopharmaceutical and radioisotope use, which has been facilitated by the development in the volume of procedures. This further increases the production of isotopes domestically and the incorporation of nuclear medicine in the routine clinical practices. Increased investments in cyclotron infrastructure, better access to short half-life isotopes, and exchange demand in its leadership in leading markets, such as China and India, enhance accessibility and reliability of supply. Additionally, the trend toward accurate diagnostics and radioligand-targeted therapies is gaining momentum in adoption, which will lead to robust market growth in the region during the forecast period.

 

• Published: February 2026

Global Allergy Autoimmune Disease Diagnostics Market - Strategic Industry Overview

The allergy autoimmune disease diagnostics market is expanding steadily, supported by the rising burden of autoimmune and allergic disorders, growing clinical awareness, and broader adoption of precision-based testing approaches. Demand remains strong across hospitals, diagnostic laboratories, and research institutions as healthcare systems increasingly prioritize early detection and personalized treatment pathways. Key revenue streams stem from multi-allergen panels, autoimmune biomarker assays, molecular diagnostic solutions, point-of-care platforms, and integrated laboratory information systems. Strategic collaborations among diagnostic manufacturers, biopharmaceutical companies, and laboratory service providers are further shaping the competitive landscape. Ongoing investments in advanced technologies and high-throughput testing capabilities continue to strengthen the market ecosystem and accelerate clinical adoption.

• Published: February 2026

GE HealthCare (US) and Cardinal Health (US) are Leading Players in the US Nuclear Medicine Market

The US nuclear medicine market is projected to reach USD 9.56 billion by 2030 from USD 4.81 billion in 2025, at a CAGR of 14.7% during the forecast period. The growth is primarily driven by the increasing prevalence of cancer, cardiovascular, and neurological diseases, as it has led to an increased demand for more advanced diagnostic and therapeutic radiopharmaceuticals. Market expansion is also being supported by technological developments in the production of radioisotopes and targeted radioligand treatments. Additionally, the increased use of PET and SPECT imaging in clinical practice, along with the favorable reimbursement of nuclear imaging processes, is driving the market growth. The growth of the US nuclear medicine market is accelerating due to increased investments in the domestic manufacturing of radioisotopes and the continued research in the new theranostics agents.

• Published: February 2026

Global Recombinant Cell Culture Supplement Market - Strategic Industry Overview

The recombinant cell culture supplement market is witnessing strong momentum, supported by expanding biopharmaceutical research, growing biologics manufacturing capacity, and wider adoption of advanced cell culture technologies. Demand remains steady across contract development and manufacturing organizations, biotechnology companies, and research institutions seeking optimized and scalable solutions. Key offerings include growth factors, serum-free media supplements, protein expression enhancers, and chemically defined reagents that improve cell viability and productivity. Organizations are increasingly prioritizing these solutions to accelerate biologic development, enhance production efficiency, and maintain regulatory standards. Strategic collaborations among biopharma companies, reagent suppliers, and academic institutions continue to strengthen innovation and drive broader adoption in therapeutic development and precision medicine.

• Published: February 2026

Global Cell Culture Media Bags Market - Strategic Industry Overview

The cell culture media bags market is experiencing strong momentum, supported by the growing adoption of single-use technologies and the continued expansion of biopharmaceutical manufacturing. Increasing investments in bioprocessing, contract manufacturing, and research activities are reinforcing steady market expansion. Flexible, sterile, and disposable media bags are becoming essential in upstream cell culture workflows, particularly with their integration into automated bioreactor systems. Demand is further driven by the need for contamination control, operational efficiency, and strict regulatory compliance. Strategic collaborations between industry participants, biopharma companies, academic institutions, and technology providers are strengthening product innovation and broadening market reach.

• Published: February 2026

Akamai (United States) and Cloudflare (United States) are the leading key players in the Europe Content Delivery Network Market

The Europe content delivery network (CDN) market is projected to grow from USD 7.75 billion in 2025 to USD 11.99 billion by 2030, at a CAGR of 9.1%. Growth is driven by rising digital consumption across streaming media, online commerce, enterprise software, financial services, and public digital platforms. European organizations increasingly serve users across multiple countries, each with different network conditions and regulatory requirements. As a result, content delivery is no longer concentrated in a limited number of centralized facilities. Instead, workloads are distributed across regional cloud infrastructure and localized edge locations to improve performance and resilience.

 

• Published: February 2026

BASF SE (Germany) and Syngenta AG (Switzerland) are the leading key players in the North America Biostimulant Market

The North America biostimulant market is estimated to be valued at USD 0.95 billion in 2025 and is projected to reach USD 1.69 billion by 2030, growing at a CAGR of 12.1% during the forecast period. This market is among the fastest-growing globally, driven by the growing adoption of sustainable, organic, and regenerative farming practices. Growers are seeking solutions that maximize crop yields and enhance resilience to abiotic stresses such as drought, temperature fluctuations, and soil degradation. A supportive regulatory environment, incentives for sustainable agricultural practices, and the rise of organic certification programs in the US, Canada, and Mexico have accelerated this adoption. The US market is particularly robust, due to advanced agronomic practices and significant investments in biological inputs. Meanwhile, Canada benefits from large-scale cereal and oilseed production, and Mexico has opportunities in its high-value horticulture crops.

 

• Published: February 2026

Microsoft (US) and Google (US) are the leading key players in the US Cloud Computing Market

The US cloud computing market is expanding rapidly, with its size anticipated to reach USD 721.30 billion by 2030 from an estimated USD 485.54 billion in 2025, featuring a CAGR of 8.2%. The market is driven by enterprise modernization and ongoing digital transformation across industries. Organizations are migrating legacy workloads to cloud platforms to improve flexibility, handle growing data volumes, and support distributed workforces. Government cloud-first and zero-trust policies are increasing demand for secure and compliant cloud services, especially in regulated sectors. Rising adoption of AI applications and advanced analytics is increasing demand for high-performance compute and scalable storage. Enterprises are expanding hybrid and multi-cloud strategies to improve resilience, manage costs, and meet sector-specific regulations. Major hyperscalers continue to invest in new data center regions, edge infrastructure, and AI-focused compute capacity. Sustainability is gaining importance, with cloud providers increasing renewable energy use and improving cooling efficiency. Cloud computing continues to play a central role in supporting digital operations and business growth in the US.

 

• Published: February 2026

Global Automated Cell Culture Market - Strategic Industry Overview

The automated cell culture market is witnessing steady growth as organizations prioritize scalable, reproducible, and contamination-controlled cell production across biopharmaceutical manufacturing, regenerative medicine, and advanced therapy development. Adoption of automation platforms is accelerating as stakeholders aim to reduce manual variability, enhance process consistency, and enable seamless transition from research to commercial-scale production. The market is increasingly viewed as a foundational enabler for advanced therapy manufacturing, supporting closed-system operations, continuous processing, and regulatory-compliant workflows. Growing investments from pharmaceutical companies, contract manufacturing organizations, and academic institutions are strengthening demand for robotic culture systems, integrated incubation solutions, and automated media handling technologies.

• Published: February 2026

Global Cell Culture Protein Surface Coating Market - Strategic Industry Overview

The cell culture protein surface coating market is expanding steadily, driven by increasing biopharmaceutical research, broader adoption of cell-based assays, and the growing use of advanced culture platforms in academic and commercial laboratories. Rising demand for extracellular matrix proteins, recombinant adhesion factors, and serum-free coatings reflects a strong focus on reproducibility, contamination control, and standardized growth environments. The market remains closely tied to upstream life sciences investment, particularly in biologics development, regenerative medicine, and cell and gene therapy workflows. Pharmaceutical companies, biotechnology firms, and contract research organizations are prioritizing high-performance coatings to ensure consistent cell attachment, proliferation, and differentiation. Strategic collaborations between reagent suppliers and bioprocess solution providers continue to strengthen the ecosystem by enabling more integrated and efficient laboratory workflows.

• Published: February 2026

Global Epithelial Cell Culture Media Market - Strategic Industry Overview

The epithelial cell culture media market is witnessing steady growth, driven by expanding investments in life sciences research, cell-based studies, and translational medicine initiatives. Demand remains strong from pharmaceutical and biotechnology companies, academic institutions, and contract research organizations, particularly for applications in drug discovery, toxicity assessment, regenerative medicine, and oncology research where epithelial cell models play a critical role. The market is further supported by a growing preference for standardized, serum-free, and chemically defined formulations that improve reproducibility and regulatory alignment. Industry participants are also advancing specialized, value-added media solutions designed for specific epithelial cell types, including airway, renal, intestinal, and dermal models, reinforcing the market’s research and clinical relevance.

• Published: February 2026

Global Cell Culture Monitoring Biosensor Market - Strategic Industry Overview

The cell culture monitoring biosensor market is expanding steadily as biopharmaceutical manufacturers, cell therapy developers, and research institutions increasingly adopt real-time, non-invasive monitoring solutions. Growing demand for advanced process analytical technologies is enabling continuous tracking of critical culture parameters, improving process visibility and operational control. Pharmaceutical and biotechnology companies are integrating biosensor-enabled systems to enhance batch consistency, minimize variability, and strengthen regulatory compliance. Market growth is closely tied to the advancement of biologics, monoclonal antibodies, vaccines, and advanced therapies, where precise process control and reproducibility are essential. Adoption remains strongest among large biopharma firms, contract development and manufacturing organizations, and translational research institutes focused on scalable and automated cell culture platforms.

• Published: February 2026

Global Cell Culture Sampling Device Market - Strategic Industry Overview

The cell culture sampling device market is expanding steadily, driven by rising biologics manufacturing, advancing cell and gene therapy pipelines, and increasing adoption of closed-system bioprocessing. Demand for aseptic and contamination-controlled sampling solutions continues to grow across biopharmaceutical production, vaccine development, and advanced therapies. The market remains closely linked to upstream bioprocessing investments, particularly in monoclonal antibodies, recombinant proteins, and cell-based platforms. Manufacturers are focusing on single-use and closed sampling technologies to strengthen process integrity, regulatory compliance, and operational efficiency. Sustained capital investments from biopharma companies, CDMOs, and research institutions further support scalable and high-quality cell culture operations.

• Published: February 2026

Oracle (US) and TATA Consultancy Services Limited (India) are Leading Players in the Asia Pacific Patient Engagement Solutions Market

The Asia Pacific patient engagement solutions market is projected to reach USD 7.48 billion by 2030 from USD 3.97 billion in 2025, at a CAGR of 13.5% during the forecast period. This growth is driven by the rising need for individualized healthcare, increased awareness of preventive care and wellness management, and the growing role of the private healthcare providers in the Asia Pacific region. Moreover, the shortage of healthcare workers, especially in rural communities, is accelerating the integration of digital engagement tools to enhance access to care and its efficiency. The market is benefiting from AI & analytics advancements, and wearable technologies, which are allowing for the monitoring of patients more proactively, enhancing treatment adherence, and achieving improved clinical outcomes.

• Published: February 2026

Oracle (US) and Koninklijke Philips NV (Netherlands) are Leading Players in the Europe Patient Engagement Solutions Market

The patient engagement solutions market in Europe is projected to reach USD 13.37 billion by 2030 from USD 7.35 billion in 2025, at a CAGR of 12.7% during the forecast period. The market is driven by the rising digitalization of healthcare systems, increasing need for patient-centered care models, and growing adoption of mobile health and telehealth tools. The market is also supported by positive government policies that favor the integration of health IT, the usage of electronic health records, and the necessity to enhance the quality of care and lower healthcare expenditure. Furthermore, the rising prevalence of chronic illnesses, aging population, and advancements in data analytics and artificial intelligence for personalized patient engagement are all driving market growth in Europe.

• Published: February 2026

Agilent Technologies (US) and Danaher (US) are the leading key players in the Environmental Monitoring Market

The global environmental monitoring market is projected to grow from USD 16.10 billion in 2025 to USD 21.14 billion by 2030, at a CAGR of 5.6%. The growth of the environmental monitoring market is primarily driven by stringent pollution-monitoring standards from governments, deteriorating air quality due to rising particulate matter (PM2.5) levels, and heightened health concerns. Additionally, increasing government regulations, advancements in sensor technologies, and growing awareness of environmental sustainability are driving demand for accurate, real-time monitoring solutions, making environmental analysis an essential element of pollution control, resource management, and regulatory compliance globally.

 

• Published: February 2026

Grundfos (Denmark) and Xylem (US) are Leading Players in the Centrifugal Pump Market

The global centrifugal pump market is expected to grow at a CAGR of 6.4% during the forecast period, from an estimated USD 43.29 billion in 2025 to USD 58.94 billion in 2030.

• Published: February 2026

Moodys Analytics and Salesforce are Leading Players in the Advanced Analytics Market

The advanced analytics market is estimated to be USD 97.17 billion in 2026 and is projected to reach USD 193.23 billion by 2031, registering a CAGR of 14.7%. The market is being driven by a growing set of practical enterprise needs rather than experimental innovation alone. One major driver is the increasing complexity of regulatory and compliance requirements, especially in sectors such as BFSI, healthcare, energy, and government, where organizations must generate auditable, data-backed decisions quickly and consistently. Another driver is the shortage of skilled analytics and data science talent, which is pushing enterprises to adopt platforms that automate modeling, insight generation, and decision workflows to reduce dependency on specialized resources. The market is also driven by the rising demand for explainable and governed analytics, as business leaders and regulators require transparency into how insights and decisions are produced. Together, these drivers are accelerating the adoption of advanced analytics platforms that balance automation with control, trust, and operational reliability.

• Published: February 2026

BASF SE (Germany) and POSCO Future M (South Korea) are Leading Players in the Lithium-Ion Battery Materials Market

The global lithium-ion battery materials market is projected to grow from USD 48.29 billion in 2025 to USD 95.34 billion in 2030, at a CAGR of 14.6% during the forecast period. The market experiences its main market expansion due to the increase in electric vehicle production, which creates higher demand for cathode, anode, electrolyte, and other materials. Further growth is expected through increased installations of energy storage systems, which support renewable power integration and maintain grid stability as worldwide solar and wind capacity expands. Scientists develop new materials to create batteries with higher energy capacity, longer lifespan, and improved safety features. The market experiences robust growth because the customer electronics and industrial markets maintain consistent product demand.

• Published: February 2026

A.O. Smith (US) and Grupo Rotoplas, S.A.B. de C.V. (Mexico) are Leading Players in the North America Point-of-use Water Treatment Systems Market

The market for point-of-use water treatment systems in North America is projected to grow from USD 2.36 billion in 2025 to USD 3.03 billion in 2030 at a CAGR of 5.12%.

• Published: February 2026

ARMACELL (Luxembourg) and Kingspan Insulation, LLC (Ireland) are Leading Players in the Europe Polymer Foam Market

The polymer foam market in Europe is projected to grow from USD 26.11 billion in 2024 to USD 34.18 billion by 2030, at a CAGR of 4.6% during the forecast period. The market growth in Europe is strongly influenced by advancements in lightweight materials, energy-efficient construction solutions, and sustainability-driven manufacturing practices. Polymer foams are increasingly being adopted across automotive, construction, and packaging industries due to their superior insulation, cushioning, and energy absorption properties. The region's commitment to carbon neutrality and circular economy objectives under the European Green Deal is accelerating the transition toward bio-based and recyclable foam solutions. In the mobility sector, demand for lightweight polyurethane and polyolefin foams is rising as automakers focus on improving fuel efficiency and reducing emissions in electric and hybrid vehicles. Within the construction industry, the use of rigid polyurethane and polystyrene foams is expanding rapidly, supported by stricter building energy codes and the Renovation Wave initiative. Additionally, the growing digital infrastructure across Europe, including the expansion of data centers, is driving demand for advanced insulation and thermal management materials. Together, these developments are positioning polymer foams as essential components in Europe's sustainable manufacturing and energy-efficient future.

• Published: February 2026

GE Healthcare (US) and Siemens Healthineers (Germany) are the leading key players in the US MRI System Market

The increasing prevalence of chronic diseases, particularly neurological conditions like Alzheimer’s disease, cardiovascular issues such as myocardial infarction, and musculoskeletal disorders like osteoarthritis, continues to drive growth in the US MRI systems market. Furthermore, the increasing integration of artificial intelligence (AI) capabilities into MRI systems and the development of outpatient radiology facilities are significant factors driving this expansion. Key advancements include AI-enhanced imaging, innovative helium-free and low-helium magnet designs, the emergence of portable and point-of-care MRI systems, the introduction of higher magnetic field-strength systems (such as 3T+ MRI), and improved patient comfort during MRI procedures.

 

• Published: February 2026

Global Probiotics Market Analysis: Trends, Segmentation, and Forecast

According to a research report published by MarketsandMarkets, the probiotics market is projected to reach USD 105.7 billion by 2029 from USD 71.2 billion by 2024, growing at a CAGR of 8.2% during the forecast period in terms of value.

• Published: February 2026

H.B. Fuller Company (US) and 3M Company (US) are Leading Players in the North America Adhesives and Sealants Market

The North America adhesives & sealants market is projected to grow from USD 21.17 billion in 2025 to USD 23.92 billion by 2030 at a growth rate of 2.47% during the forecast period. The market has been experiencing slow but steady growth with the high regulatory standards in terms of emissions, safety, and material performance, and the increasing concern about product reliability and longevity in terms of end-use applications. Market expansion is also supported by the growing demand for automotive, building, packaging, electronic, health, and aerospace sectors.

• Published: February 2026

Umicore (Belgium) and Fortum (Finland) are Leading Players in the Europe Battery Recycling Market

The Europe battery recycling market is projected to grow from USD 8.74 billion in 2025 to USD 15.22 billion by 2030, at a CAGR of 11.7% during the forecast period. The Europe battery recycling market is witnessing strong growth, driven by rapidly expanding electric vehicle deployment, stringent EU regulations on waste battery management, and accelerated investments in regional circular-economy infrastructure. The implementation of the EU Battery Regulation mandating higher recycled content, strict collection targets, and end-of-life processing obligations is compelling OEMs, gigafactories, and recyclers to establish localized, large-scale recycling ecosystems. In parallel, rising volumes of end-of-life consumer electronics and industrial batteries are reinforcing demand for advanced hydrometallurgical and low-carbon recycling technologies.

• Published: February 2026

Global Probiotics Market Report: Growth Drivers, Applications & Regional Analysis

According to a research report published by MarketsandMarkets, The global probiotics industry is entering a strong expansion phase, reflecting a broader shift toward preventive healthcare and nutrition-led wellness. According to a research study highlighted in a leading probiotics market report, the market is projected to grow from USD 71.2 billion in 2024 to USD 105.7 billion by 2029, registering a CAGR of 8.2% during the forecast period.

• Published: February 2026

Thermo Fisher Scientific (US) and Shimadzu Corporation (Japan) are the leading key players in the Europe Chromatography Accessories & Consumables Market

The Europe chromatography accessories and consumables market is projected to grow from USD 1.78 million in 2026 to USD 2.53 billion by 2031, at a CAGR of 7.2% during this period. The Europe chromatography accessories & consumables market is witnessing significant growth, driven by several key factors. Strict regulatory standards in pharmaceuticals, food safety, and environmental monitoring across Europe compel laboratories to perform high‑precision testing, boosting demand for consumables such as columns, vials, syringes, and filters. The strong presence of pharmaceutical, biotechnology, and life sciences R&D hubs, especially in Germany, the UK, and France, has probably led to increased use of chromatography for drug development, biologics analysis, metabolite profiling, and quality control, Besides pharma, expanding applications such as food, safety testing, environmental contaminant analysis, and forensic or clinical diagnostics are leading to a greater dependence on chromatography accessories. Technological innovations, particularly the move to automation and high-throughput workflows with pre-packed columns, auto-samplers, and automated sample-prep kits, are resulting in repeated consumable usage, thus fortifying steady market growth.

 

• Published: February 2026

Shimadzu Corporation (Japan) and PerkinElmer Inc (US) are the leading key players in the Asia Pacific Chromatography Accessories and Consumables Market

One of the key factors driving this market is the increasing demand for analytical testing across numerous industries. The current trend of increased drug development, the emphasis on quality control testing, and the increase in regulations are contributing to the use of chromatography systems in laboratories to create high-quality products that meet the growing demand for quality, compliance, and the creation of high-quality columns, vials, syringes, filters, and other consumables. There is a market trend that indicates an increase in demand for chromatography consumables used in biopharmaceutical R&D to ensure high accuracy, reliability, and reproducibility. Technology advancements and automation/high-throughput workflows are contributing to the use of chromatography in biotech R&D, in turn contributing to this market’s growth.

 

• Published: February 2026

Fortive (US) and Thermo Fisher Scientific Inc. (US) are the key leading key players in the Asia Pacific Radiation Detection, Monitoring & Safety Market

Several key factors have driven growth in this market, including the rapid industrialization of many areas such as nuclear power, healthcare, and manufacturing, which rely heavily on radiation safety. Additionally, increased focus on public health and safety, along with stricter government regulations and standards for radiation protection, have supported the rising demand for monitoring and safety equipment. The adoption of nuclear energy for power generation in China and India, along with advancements in medical imaging and radiation therapy, has further accelerated industry growth. Moreover, the launch of technologically advanced radiation monitoring methods—such as real-time monitoring systems and automated detection devices—continues to fuel expansion, as companies seek greater efficiency, reliability, and cost savings in radiation safety. Leading players in this market include Fortive (US), Mirion Technologies, Inc. (US), AMETEK, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Fuji Electric Co., Ltd. (Japan), among others.

 

• Published: February 2026

Thermo Fisher Scientific Inc. (US) and QIAGEN (Germany) are Leading players in the Nucleic Acid Isolation and Purification Kits Market

The nucleic acid isolation and purification kits market is anticipated to reach USD 4.82 billion by 2030 from USD 3.02 billion in 2025, at a CAGR of 9.8% during the forecast period. The nucleic acid isolation and purification kits market is largely influenced by the continued expansion of molecular diagnostics and the increasing volume of PCR/RT-PCR and sequencing-based testing in clinical and research laboratories.

• Published: February 2026

Thermo Fisher Scientific (US) and Mirion Technologies, Inc. (US) are the leading key players in the Europe Radiation Detection, Monitoring, and Safety Market

 The major factors that help in the market development are the implementation of the strict radiation safety regulations in the EU, increased investments in the nuclear power sector for capacity enhancement, and the growing need for real-time monitoring systems in the industrial and healthcare sectors. Healthcare centers and radiology units are swiftly adopting advanced digital dosimetry solutions that can ensure the accurate recording of dosage both for the doctors and patients, according to EURATOM and local regulatory standards.

 

• Published: February 2026

Mphasis (India) and Readinow (Australia) are Leading Players in the Asia Pacific eGRC Market

The Asia Pacific enterprise, governance, risk, and compliance (eGRC) market is projected to grow from USD 3.94 billion in 2025 to USD 7.87 billion by 2030, at a CAGR of 14.9% during the forecast period. Enterprises in the Asia Pacific region are rapidly adopting eGRC solutions due to the increasing frequency of cyberattacks, data breaches, and growing business interruption risks. As cyber threats intensify, organizations across the region are prioritizing stronger governance, compliance, and risk management, driving sustained growth in the Asia Pacific eGRC market. Intense regulatory pressure, especially in BFSI, where bodies like the China Banking and Insurance Regulatory Commission enforce strict compliance, is further accelerating the adoption of eGRC solutions and services in the region.

• Published: February 2026